Teacher-recorded classroom engagement scores beat GPA at identifying middle schoolers who reported alcohol or cannabis use by eighth grade.
|Articles|October 20, 2016
Psychiatry Comic: Ruffled Feathers
Author(s)Jonny Hawkins
Almost everyone can benefit from psychotherapy at some point in their lives.
Advertisement
[[{"type":"media","view_mode":"media_crop","fid":"53029","attributes":{"alt":"","class":"media-image","id":"media_crop_8576766434998","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6595","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
©JonnyHawkins/PsychiatricTimes
Advertisement
Related to this article
The FDA seems to have shelved the fast-track drug review initiative launched during the Trump administration.
Oveporexton (Orzeyful) is now available in the US by prescription for the treatment of narcolepsy type 1.
Explore the types of scams encountered in psychiatric practice in order to help identify those at risk.
Mixed-feature depression can signal bipolar risk; spot red flags and consider lurasidone or lumateperone before standard antidepressants.
Explore how OCD and schizophrenia overlap, complicating diagnosis and care, and learn spectrum-based strategies and treatment pitfalls for managing schizo-obsessive symptoms.
How estrogen dips during menstruation, pregnancy, postpartum, and menopause can trigger schizophrenia relapse, and what it means for antipsychotic dosing.
Psychiatric Times honors those who served with reflections from a World War I diary and new studies on veteran PTSD and suicide risk.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Schizo-Obsessed! Untangling the Overlap Between Obsessive Compulsive Disorder and Schizophrenia
2
Can Digital Memory Tests Detect Tau-Related Cognitive Change Before Alzheimer Disease?
3
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
4
New National Guidance for Managing Medetomidine Intoxication and Withdrawal
5